7Baggers
 ZyVersa Therapeutics Delays 10-Q Filing  TipRanks Fri, 14 Nov 2025 23:23:06 GMT
 relative strength of zyversa therapeutics inc. in sector analysis  newser.com Wed, 05 Nov 2025 07:16:20 GMT

ZyVersa Therapeutics, Inc.
(NASDAQ:ZVSA) 

ZVSA stock logo

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and...

Founded: 2014
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends